References
  1. Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. International Journal of Hematology. 2020:1-13.
  2. Arachchillage DR, Shi C, Saliu D, Kozman P, Mi E, Buti N, et al., editors. Efficacy Safety and of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19). Seminars in Thrombosis and Hemostasis; 2021: Thieme Medical Publishers, Inc.
  3. Bhatia R, Srivastava MP. COVID-19 and stroke: Incidental, triggered or causative. Annals of Indian Academy of Neurology. 2020;23(3):318.
  4. Canzano P, Brambilla M, Porro B, Cosentino N, Tortorici E, Vicini S, et al. Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients. Basic to Translational Science. 2021;6(3):202-18.
  5. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020;395(10223):507-13.
  6. Fruchter O, Yigla M, Kramer MR. D-dimer as a prognostic biomarker for mortality in chronic obstructive pulmonary disease exacerbation. The American journal of the medical sciences. 2015;349(1):29-35.
  7. Snijders D, Schoorl M, Schoorl M, Bartels PC, van der Werf TS, Boersma WG. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial. European Journal of internal medicine. 2012;23(5):436-41.
  8. Tayman C, Tonbul A, Akca H, Bilici M. Mean platelet volume (MPV) may simply predict the severity of sepsis in preterm infants. Clin Lab. 2014;60(7):1193-200.
  9. Manolis AS, Manolis TA, Manolis AA, Papatheou D, Melita H. COVID-19 infection: viral macro-and micro-vascular coagulopathy and thromboembolism/prophylactic and therapeutic management. Journal of Cardiovascular Pharmacology and Therapeutics. 2021;26(1):12-24.
  10. Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. Journal of thrombosis and thrombolysis. 2020:1-4.
  11. Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association? European heart journal. 2020;41(19):1858-.
  12. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506.
  13. Zhong Q, Peng J. Mean platelet volume/platelet count ratio predicts severe pneumonia of COVID‐19. Journal of clinical laboratory analysis. 2021;35(1):e23607.
  14. Lippi G, Henry BM, Favaloro EJ, editors. Mean Platelet Volume Predicts Severe COVID-19 Illness. Seminars in Thrombosis and Hemostasis; 2021: Thieme Medical Publishers, Inc.
  15. Guner Ozenen G, Sahbudak Bal Z, Umit Z, Bilen NM, Yildirim Arslan S, Yurtseven A, et al. Demographic, clinical, and laboratory features of COVID‐19 in children: The role of mean platelet volume in predicting hospitalization and severity. Journal of Medical Virology. 2021;93(5):3227-37.
  16. Aktaş A, Sener K, Yılmaz N, Tunç M, Yolcu S. Is Mean Platelet Volume Useful for Predicting the Prognosis of COVID-19 Diagnosed Patients? Age. 2020;54(18,191):18,191.
  17. Mouhat B, Besutti M, Bouiller K, Grillet F, Monnin C, Ecarnot F, et al. Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients. European Respiratory Journal. 2020;56(4).
  18. Song X, Ji J, Reva B, Joshi H, Calinawan AP, Mazumdar M, et al. Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortality. ERJ Open Research. 2021.
  19. Liu X, Li Z, Liu S, Chen Z, Zhao Z, Huang Y-y, et al. Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction. MedRxiv. 2020.
  20. Guo L, Wei D, Zhang X, Wu Y, Li Q, Zhou M, et al. Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score. Frontiers in microbiology. 2019;10:2752.
  21. Vizcaychipi MP, Shovlin CL, McCarthy A, Godfrey A, Patel S, Shah PL, et al. Increase in COVID-19 inpatient survival following detection of Thromboembolic and Cytokine storm risk from the point of admission to hospital by a near real time Traffic-light System (TraCe-Tic). The Brazilian Journal of Infectious Diseases. 2020;24(5):412-21.
  22. Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021;88(1):14-26.
  23. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama. 2020;323(13):1239-42.
  24. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020;395(10229):1054-62.
  25. Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. Journal of hematology & oncology. 2020;13(1):1-22.
  26. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature. 2020;579(7798):270-3.
  27. Fan BE. Hematologic parameters in patients with COVID‐19 infection: a reply. American journal of hematology. 2020.
  28. Arachchillage DR, Laffan M. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis. 2020;18(5):1233-4.
  29. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9.